{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T05:18:01Z","timestamp":1787807881905,"version":"build-2784847793"},"reference-count":51,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>RNA sequencing (RNA-seq) has become an important tool for investigating the molecular heterogeneity of acute myeloid leukemia (AML); however, the global development and thematic evolution of this field remain inadequately characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To map the global landscape of AML RNA-seq research and identify major knowledge domains, emerging themes, and temporal changes in research priorities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Publications indexed in the Web of Science Core Collection and Scopus between January 1, 2007, and August 18, 2025, were retrieved. After database filtering, merging, and deduplication, 3,460 articles and reviews were included. CiteSpace, VOSviewer, the bibliometrix R package, and Microsoft Excel were used to analyze publication trends, collaboration networks, co-citation structures, keyword evolution, and citation bursts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Publication output increased steadily, accelerating after 2014. China contributed the largest number of publications (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f547, 15.8%), whereas the United States had the highest total citation count. Major publication outlets spanned hematology, oncology, genomics, and molecular biology. Co-citation analysis identified prominent themes involving next-generation sequencing, gene mutations, KMT2A rearrangements, epigenetic dysregulation, leukemia-initiating cells, drug resistance, biomarkers, T-cell biology, and single-cell sequencing. Earlier literature emphasized sequencing technologies, gene expression profiling, and molecular alterations, whereas recent publications show increasing representation of cellular heterogeneity, single-cell transcriptomics, drug resistance, biomarker applications, immune-related research, and computational interpretation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While molecular characterization remains foundational, AML RNA-seq research has broadened to encompass increasingly prominent cellular, functional, computational, and translational dimensions. This study provides a structured overview of the field; nevertheless, bibliometric prominence should not be interpreted as direct evidence of clinical utility.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1877223","type":"journal-article","created":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:17Z","timestamp":1787804837000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From transcriptomic profiling to precision oncology: a bibliometric analysis of RNA sequencing in acute myeloid leukemia"],"prefix":"10.3389","volume":"13","author":[{"given":"Yuye","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Hematology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hematology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenya","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Hematology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, First Hospital of Shanxi Medical University","place":["Taiyuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,27]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.blre.2019.04.005","article-title":"Epidemiology of acute myeloid leukemia: recent progress and enduring challenges","volume":"36","author":"Shallis","year":"2019","journal-title":"Blood Rev"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"3811","DOI":"10.1080\/14796694.2025.2587568","article-title":"Real-world treatment and utilization of venetoclax for incident acute myeloid leukemia in a Medicare population","volume":"21","author":"Roth","year":"2025","journal-title":"Future Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1038\/s41467-021-22625-y","article-title":"A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia","volume":"12","author":"Docking","year":"2021","journal-title":"Nat Commun"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/ajh.26141","article-title":"The transcriptome-wide landscape of molecular subtype-specific mRNA expression profiles in acute myeloid leukemia","volume":"96","author":"Mou","year":"2021","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3324\/haematol.2021.278436","article-title":"Fusion gene detection by RNA-sequencing complements diagnostics of acute myeloid leukemia and identifies recurring NRIP1-MIR99AHG rearrangements","volume":"107","author":"Kerbs","year":"2022","journal-title":"Haematologica"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-018-0623-z","article-title":"Functional genomic landscape of acute myeloid leukaemia","volume":"562","author":"Tyner","year":"2018","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12964-025-02568-3","article-title":"A proteogenomic gene signature defines prognostic subgroups highlighting PI3K\/AKT\/mTOR signaling pathway as a therapeutic vulnerability in myeloid malignancies","volume":"24","author":"He","year":"2025","journal-title":"Cell Commun Signal"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"2594370","DOI":"10.1080\/16078454.2025.2594370","article-title":"TMEM91::TAL1 fusion gene in a middle-aged female with rapid MDS to secondary AML progression: a case report","volume":"30","author":"Huang","year":"2025","journal-title":"Hematology"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1182\/bloodadvances.2023010435","article-title":"Monosomy 7\/del(7q) cause sensitivity to inhibitors of nicotinamide phosphoribosyltransferase in acute myeloid leukemia","volume":"8","author":"Eldfors","year":"2024","journal-title":"Blood Adv"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature20598","article-title":"A 17-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.clml.2025.03.005","article-title":"Advancing the management of CH, MDS, and AML from the first bridging the gaps in Leukemia, lymphoma, and multiple myeloma conference","volume":"25","author":"Carraway","year":"2025","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.62347\/VXBP2060","article-title":"Role and mechanism of the CBX4-HDAC5-CERS6 axis in disrupting sphingomyelin metabolism in acute myeloid leukemia","volume":"15","author":"Ye","year":"2025","journal-title":"Am J Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5045\/br.2020.55.1.1","article-title":"Bibliometric analysis of studies about acute myeloid leukemia conducted globally from 1999 to 2018","volume":"55","author":"Seo","year":"2020","journal-title":"Blood Res"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"957370","DOI":"10.3389\/fonc.2022.957370","article-title":"The research progress of targeted therapy in acute myeloid leukemia based on bibliometric analysis","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1291195","DOI":"10.3389\/fphar.2023.1291195","article-title":"A global bibliometric and visualized analysis of the links between the autophagy and acute myeloid leukemia","volume":"14","author":"Gao","year":"2023","journal-title":"Front Pharmacol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"2448888","DOI":"10.1080\/21645515.2024.2448888","article-title":"Hotspots evolution and frontiers of immunotherapy for the treatment of acute myeloid leukemia: a bibliometric analysis","volume":"21","author":"Zhe","year":"2025","journal-title":"Hum Vaccin Immunother"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1285599","DOI":"10.3389\/fgene.2023.1285599","article-title":"Bibliometric and visual analysis of single-cell sequencing from 2010 to 2022","volume":"14","author":"Chen","year":"2024","journal-title":"Front Genet"},{"key":"ref19","article-title":"Comparing bibliometric analysis using PubMed, Scopus, and web of science databases","volume":"152","author":"AlRyalat","year":"2019","journal-title":"J Vis Exp"},{"key":"ref20","first-page":"724","article-title":"CiteSpace II: visualization and knowledge discovery in bibliographic databases","volume":"2005","author":"Synnestvedt","year":"2005","journal-title":"AMIA Annu Symp Proc"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11192-009-0146-3","article-title":"Software survey: VOSviewer, a computer program for bibliometric mapping","volume":"84","author":"van Eck","year":"2010","journal-title":"Scientometrics"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"392","DOI":"10.5195\/jmla.2022.1434","article-title":"VOSviewer and Bibliometrix","volume":"110","author":"Arruda","year":"2022","journal-title":"J Med Libr Assoc"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1056\/NEJMoa1716863","article-title":"Molecular minimal residual disease in acute myeloid leukemia","volume":"378","author":"Jongen-Lavrencic","year":"2018","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int J Oral Sci"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1016\/j.cell.2019.01.031","article-title":"Single-cell RNA-seq reveals AML hierarchies relevant to disease progression and immunity","volume":"176","author":"van Galen","year":"2019","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13045-020-00941-y","article-title":"A single-cell survey of cellular hierarchy in acute myeloid leukemia","volume":"13","author":"Wu","year":"2020","journal-title":"J Hematol Oncol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cell.2019.04.040","article-title":"A cellular taxonomy of the bone marrow stroma in homeostasis and Leukemia","volume":"177","author":"Baryawno","year":"2019","journal-title":"Cell"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"e159579","DOI":"10.1172\/JCI159579","article-title":"Immune dysfunction signatures predict outcomes and define checkpoint blockade-unresponsive microenvironments in acute myeloid leukemia","volume":"132","author":"Rutella","year":"2022","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/2159-8290.cd-19-0710","article-title":"Monocytic subclones confer resistance to venetoclax-based therapy in patients with acute myeloid leukemia","volume":"10","author":"Pei","year":"2020","journal-title":"Cancer Discov"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1182\/blood.2021013626","article-title":"2021 update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD working party","volume":"138","author":"Heuser","year":"2021","journal-title":"Blood"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.ccell.2023.10.008","article-title":"A longitudinal single-cell atlas of treatment response in pediatric AML","volume":"41","author":"Lambo","year":"2023","journal-title":"Cancer Cell"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41375-022-01789-6","article-title":"Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed\/refractory acute myeloid leukemia","volume":"37","author":"Li","year":"2023","journal-title":"Leukemia"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"256","DOI":"10.3978\/j.issn.2218-676X.2015.06.04","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Transl Cancer Res"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13059-016-0881-8","article-title":"A survey of best practices for RNA-seq data analysis","volume":"17","author":"Conesa","year":"2016","journal-title":"Genome Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"4056","DOI":"10.1158\/1078-0432.CCR-22-1102","article-title":"Biological misinterpretation of transcriptional signatures in tumor samples can unknowingly undermine mechanistic understanding and faithful alignment with preclinical data","volume":"28","author":"Fisher","year":"2022","journal-title":"Clin Cancer Res"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/s41587-020-0469-4","article-title":"Benchmarking single-cell RNA-sequencing protocols for cell atlas projects","volume":"38","author":"Mereu","year":"2020","journal-title":"Nat Biotechnol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.ircmb.2024.08.001","article-title":"DOGMA-seq and multimodal, single-cell analysis in acute myeloid leukemia","volume":"390","author":"Kim","year":"2025","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1038\/s41587-021-00927-2","article-title":"Scalable, multimodal profiling of chromatin accessibility, gene expression and protein levels in single cells","volume":"39","author":"Mimitou","year":"2021","journal-title":"Nat Biotechnol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"103798","DOI":"10.1016\/j.isci.2022.103798","article-title":"Machine learning for multi-omics data integration in cancer","volume":"25","author":"Cai","year":"2022","journal-title":"iScience"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"e078378","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"e082505","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"BMJ"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41586-021-03634-9","article-title":"Exploring tissue architecture using spatial transcriptomics","volume":"596","author":"Rao","year":"2021","journal-title":"Nature"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1038\/s41592-022-01409-2","article-title":"Museum of spatial transcriptomics","volume":"19","author":"Moses","year":"2022","journal-title":"Nat Methods"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41576-023-00586-w","article-title":"Best practices for single-cell analysis across modalities","volume":"24","author":"Heumos","year":"2023","journal-title":"Nat Rev Genet"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13059-019-1850-9","article-title":"A benchmark of batch-effect correction methods for single-cell RNA sequencing data","volume":"21","author":"Tran","year":"2020","journal-title":"Genome Biol"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/GIM.0b013e318184137c","article-title":"The evaluation of genomic applications in practice and prevention (EGAPP) initiative: methods of the EGAPP working group","volume":"11","author":"Teutsch","year":"2009","journal-title":"Genet Med"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1877223\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:27:20Z","timestamp":1787804840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1877223\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,27]]},"references-count":51,"alternative-id":["10.3389\/fmed.2026.1877223"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1877223","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,27]]},"article-number":"1877223"}}